
Zentek Ltd. — Investor Relations & Filings
Zentek Ltd. is an intellectual property (IP) development and commercialization company specializing in nanotechnology. It leverages expertise in nanomaterials, particularly graphene, to research, develop, and patent advanced solutions for the healthcare, safety, and environmental sectors. The company's primary focus is on creating technologies for prevention, detection, and treatment. Its flagship commercial product is ZenGUARD™, a proprietary graphene-based antimicrobial coating that enhances the pathogen-filtering efficacy of personal protective equipment like surgical masks. Zentek's development pipeline also includes other advanced materials, such as graphite-based fire-retardant products, which it advances toward commercialization through strategic partnerships.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English | |
| 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-15 | English |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
10 filings
| |||||
| 45626550 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-13 | English | ||
| 41929009 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-05-06 | English | ||
| 38023632 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-28 | English | ||
| 35277900 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-22 | English | ||
| 34650021 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-16 | English | ||
| 34596920 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-15 | English | ||
| 34417504 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-13 | English | ||
| 33135818 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-04-01 | English | ||
| 33040816 | 6-K - Zentek Ltd. (0001904501) (Filer) | 2026-03-25 | English | ||
| 32199603 | 6-K Filing | 2026-01-29 | English | ||
|
2025
5 filings
| |||||
| 13569824 | FORM 6-K | 2025-12-17 | English | ||
| 13569823 | FORM 6-K | 2025-11-25 | English | ||
| 13569826 | FORM 6-K | 2025-11-21 | English | ||
| 13569829 | FORM 6-K | 2025-11-14 | English | ||
| 13569827 | FORM 6-K | 2025-11-05 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
Zentek Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34277/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34277 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34277 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34277 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34277}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Zentek Ltd. (id: 34277)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.